Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill R Blankenship

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Infection and Immunity|August 23, 2005
Calcineurin is required for Candida albicans to survive calcium stress in serumJill R Blankenship, Joseph Heitman
Journal of Biological Methods|August 28, 2019
Analysis of gene expression in filamentous cells of <i>Candida albicans</i> grown on agar platesPaul E Creger, Jill R Blankenship
Current Opinion in Microbiology|October 24, 2006
How to build a biofilm: a fungal perspectiveJill R Blankenship, Aaron P Mitchell
Cell Host & Microbe|August 17, 2011
Candida albicans adds more weight to iron regulationJill R Blankenship, Aaron P Mitchell
Genome Biology|May 25, 2007
The fungal frontierJill R Blankenship, Aaron P Mitchell
Antimicrobial Agents and Chemotherapy|February 27, 2003
Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida kruseiChiatogu Onyewu, Jill R Blankenship, Maurizio Del Poeta, et al.
Eukaryotic Cell|December 7, 2010
Interaction between the Candida albicans high-osmolarity glycerol (HOG) pathway and the response to human beta-defensins 2 and 3Silvia Argimón, Saranna Fanning, Jill R Blankenship, et al.
Journal of Clinical Microbiology|January 7, 2005
Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimensJill R Blankenship, Nina Singh, Barbara D Alexander, et al.
Plos Pathogens|February 9, 2010
An extensive circuitry for cell wall regulation in Candida albicansJill R Blankenship, Saranna Fanning, Jessica J Hamaker, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugsJill R Blankenship, William J Steinbach, John R Perfect, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Infection and Immunity|August 23, 2005
Calcineurin is required for Candida albicans to survive calcium stress in serumJill R Blankenship, Joseph Heitman
Journal of Biological Methods|August 28, 2019
Analysis of gene expression in filamentous cells of <i>Candida albicans</i> grown on agar platesPaul E Creger, Jill R Blankenship
Current Opinion in Microbiology|October 24, 2006
How to build a biofilm: a fungal perspectiveJill R Blankenship, Aaron P Mitchell
Cell Host & Microbe|August 17, 2011
Candida albicans adds more weight to iron regulationJill R Blankenship, Aaron P Mitchell
Genome Biology|May 25, 2007
The fungal frontierJill R Blankenship, Aaron P Mitchell
Antimicrobial Agents and Chemotherapy|February 27, 2003
Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida kruseiChiatogu Onyewu, Jill R Blankenship, Maurizio Del Poeta, et al.
Eukaryotic Cell|December 7, 2010
Interaction between the Candida albicans high-osmolarity glycerol (HOG) pathway and the response to human beta-defensins 2 and 3Silvia Argimón, Saranna Fanning, Jill R Blankenship, et al.
Journal of Clinical Microbiology|January 7, 2005
Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimensJill R Blankenship, Nina Singh, Barbara D Alexander, et al.
Plos Pathogens|February 9, 2010
An extensive circuitry for cell wall regulation in Candida albicansJill R Blankenship, Saranna Fanning, Jessica J Hamaker, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugsJill R Blankenship, William J Steinbach, John R Perfect, et al.
Pageof 3